WBP2 and metastatic malignant neoplasm in the lymph nodes: Notably, WBP2 expression in patients with lymph node metastasis was significantly higher than that observed in patients without lymph node metastasis (44.7 vs 70.6%, P < 0.05, Fig. 1A, B).